InnovAge Appoints James Carlson to the Board as Non-Executive Chairman

Published on June 30, 2022

DENVER, June 30, 2022 (GLOBE NEWSWIRE) -- InnovAge (NASDAQ: INNV), today announced the appointment of experienced health care executive James (“Jim”) Carlson to its Board of Directors, effective June 30, 2022. Carlson will serve as non-executive Chairman.

Continue reading on website
Other news

Leiters, a WCAS Portfolio Company, Joins the End Drug Shortages Alliance

June 29, 2022
The post Leiters, a WCAS Portfolio Company, Joins the End Drug Shortages Alliance appeared first on Leiters Health.

Abzena announces appointment of Jeffrey Mocny as Scientific Lead

July 13, 2022
Abzena, the leading Partner Research Organization (PRO) providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs) has announced the appointment of Jeffrey Mocny, Ph.D. as scientific lead.Reporting to Abzena’s Head of Scientific Leaders, Dr. Petra Dieterich, Dr Mocny will use his extensive experience with biopharmaceutical regulations to support